Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312310 · ClinicalTrials.gov registry record · NA
Dietary Flavanols and Dentate Gyrus Function
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT02312310 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 211 participants.
The verdict
NCT02312310, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
to assess the effect of differing amounts of a cocoa-derived dietary flavanol (epicatechin ) on dentate gyrus function and corresponding cognitive function
Interventions
- DIETARY_SUPPLEMENT Cocoa Flavanol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02312310
The ClinicalTrials.gov registry entry for NCT02312310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cocoa Flavanol is the first listed.
NCT02312310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02312310 about?
NCT02312310 is a clinical study titled "Dietary Flavanols and Dentate Gyrus Function". to assess the effect of differing amounts of a cocoa-derived dietary flavanol (epicatechin ) on dentate gyrus function and corresponding cognitive function
What is the current status of trial NCT02312310?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2015-12. Estimated completion is 2020-04.
What interventions are being tested in trial NCT02312310?
The interventions under investigation include: Cocoa Flavanol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02312310?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.